Trump introduces phased tariffs on generics
President Donald Trump announced a phased plan to impose tariffs on imported generic drugs to promote U.S. pharmaceutical manufacturing. Starting August 1, 2026, imported generics will face a 0% tariff for two years, then increase to 100% for one year, and ultimately 200%. The goal is to encourage companies to build or expand facilities in the U.S. and reduce dependence on foreign drug imports.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)